Pay gap widens as UK bosses get 130 times average worker’s salary In its final report the High Pay Centre says the median remuneration of a FTSE 100 CEO has risen to a record £5.06m The Guardian - UK · Jul 19
GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year The Guardian - UK · Jun 9
GSK reports promising early results in ovarian and womb cancer drug trial Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug The Guardian - UK · Apr 12
Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise The Guardian - UK · Mar 5
GSK, take two: the bullish tone at the top is finally more convincing New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential The Guardian - UK · Feb 4
GSK posts higher profits but indicates sales growth to slow in 2026 It came amid the first set of results by new chief executive Luke Miels, who took over from Emma Walmsley at the turn of the year. Evening Standard · Feb 4
The UK’s pharma deal was vital – but the GSK boss is right about US dominance It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact The Guardian - UK · Dec 11, 2025
US is the best place for drug companies to invest, says boss of London-based GSK Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government The Guardian - UK · Dec 11, 2025
UK must reform drug pricing to become life sciences superpower, says GSK boss Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolved The Guardian - UK · Oct 29, 2025
GSK boosted by cancer and HIV drugs as Emma Walmsley bows out Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year. Evening Standard · Oct 29, 2025
GSK chief doesn't buy that the CEO role has become unsustainable The co-CEO model may work with the right “cocktail” combination, but CEOs must be prepared to give the position “everything you possibly have,” she said. Fortune · Oct 15, 2025
Are trees getting taller? Plus teenage smoking and why females live longer These are the most groundbreaking stories from the new frontier of science and technology right now Evening Standard · Oct 3, 2025
Emma Walmsley steadied GSK – but doubts linger over growth targets The outgoing chief executive reshaped the drugmaker, yet scepticism persists over promised revenues The Guardian - UK · Sep 29, 2025
FTSE 100 held back by weak oil after bright start The FTSE 100 index closed up 0.2% at 9,299.84. Evening Standard · Sep 29, 2025
Benzinga · Sep 29, 2025 Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026 GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026.
The Independent UK · Sep 29, 2025 CEO of drugmaker GSK to step down by year's end GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker
The Independent UK · Sep 29, 2025 Emma Walmsley steps down as CEO of GSK as pharmaceutical industry faces upheaval The drug and vaccine maker is a £60bn firm – one of the biggest in the UK
International Business Times · Sep 29, 2025 GSK Switches CEO As Trump Tariffs Test Pharma British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.
Evening Standard · Sep 29, 2025 GSK’s boss Emma Walmsley to step down after eight-year tenure Dame Emma was the first woman to run a major pharmaceutical company when she became chief executive in 2017.
The Guardian - UK · Sep 29, 2025 GSK’s Emma Walmsley to step down as chief executive after eight years Chief commercial officer Luke Miels to take over as CEO at Britain’s second-biggest drugmaker
Evening Standard · Sep 29, 2025 FTSE 100 Live 29 September: Index nears record, GSK shares rise on CEO change GSK chief executive Emma Walmsley is to step down after more than eight years running the pharmaceuticals giant.
Fortune · May 23, 2025 Queens of influence: Meet the women shaping Europe's future In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the helm of European companies.
Evening Standard · Apr 30, 2025 Drugs giant GSK ‘well positioned’ to absorb potential US tariffs It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.
Fortune · Apr 2, 2025 GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt Emma Walmsley says her "180" would probably tell her to say "thank yous" and "well dones."
Fortune · Mar 8, 2025 Power Players: Meet the women reshaping 10 key European industries This year, Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.